Cambridge Researchers Develop Early Lung Cancer Urine Test

Researchers at the University of Cambridge have developed a pioneering urine test that could enable the early detection of lung cancer by identifying proteins released by senescent 'zombie' cells. The test aims to diagnose lung cancer before it reaches advanced stages, which currently complicates treatment options. Utilizing an injectable sensor, the test detects specific proteins that signal the presence of these zombie cells, which are associated with tissue damage and cancer development. Preliminary tests have been successful in mice, and researchers plan to move to human trials soon. Professor Ljiljana Fruk emphasized that early detection is crucial for improving patient outcomes, as only about 10% of lung cancer patients survive for ten years post-diagnosis. This innovative approach could revolutionize lung cancer screening and treatment strategies.